SCHEMBL24577629

SCHEMBL24577629

COCCn1cc(-c2cn3ncc(C(=O)Nc4cc(NC(=O)CCCl)cnc4C)c3s2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 6/20 0.41
▸ TBK1 Q9UHD2 6/20 0.41
▸ JAK2 O60674 3/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ JAK1 P23458 3/20 0.33
▸ TYK2 P29597 3/20 0.33
▸ JAK3 P52333 3/20 0.33
▸ KAT5 Q92993 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ MAP3K7 O43318 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ CSF1R P07333 2/20 0.32
▸ KIT P10721 2/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ LYN P07948 1/20 0.32
▸ TGFBR1 P36897 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29759547 1.00 IKBKE (0.41) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24577220 0.96 IKBKE (0.40) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL29759874 0.96 IKBKE (0.40) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL29759532 0.94 IKBKE (0.42) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24577285 0.94 IKBKE (0.42) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24577482 0.90 IKBKE (0.43) IKBKETBK1JAK2JAK1TYK2
SCHEMBL29759564 0.89 PDGFRA (0.41) IKBKETBK1JAK2HDAC6JAK1
SCHEMBL24578953 0.89 IKBKE (0.44) IKBKETBK1JAK2JAK1TYK2
SCHEMBL24578101 0.89 PDGFRA (0.41) IKBKETBK1JAK2HDAC6JAK1
SCHEMBL24577195 0.89 IKBKE (0.38) IKBKETBK1JAK2HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback